UBS O'Connor’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-73,441
Closed -$856K 276
2025
Q2
$856K Sell
73,441
-114,348
-61% -$1.04M 0.02% 242
2025
Q1
$1.4M Sell
187,789
-26,040
-12% -$200K 0.03% 155
2024
Q4
$1.28M Buy
213,829
+48,555
+29% +$268K 0.03% 209
2024
Q3
$846K Buy
165,274
+99,529
+151% +$434K 0.02% 296
2024
Q2
$238K Hold
65,745
0.01% 412
2024
Q1
$211K Sell
65,745
-100,000
-60% -$387K 0.01% 395
2023
Q4
$812K Sell
165,745
-35,595
-18% -$162K 0.03% 299
2023
Q3
$1.1M Buy
201,340
+1,500
+0.8% +$9.92K 0.02% 323
2023
Q2
$1.34M Buy
199,840
+21,254
+12% +$158K 0.03% 352
2023
Q1
$1.58M Buy
+178,586
New +$1.57M 0.04% 362
2022
Q4
Sell
-143,490
Closed -$1.02M 18
2022
Q3
$1.02M Sell
143,490
-70,000
-33% -$659K 0.01% 746
2022
Q2
$1.73M Buy
+213,490
New +$1.88M 0.02% 685

Other funds holding ADPT